Skip to main content
Clinical Trials/NCT07386314
NCT07386314
Not yet recruiting
Not Applicable

Motor and Cognitive Telerehabilitation for Acquired Brain Injury

Azienda USL Toscana Nord Ovest0 sites62 target enrollmentStarted: February 1, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Azienda USL Toscana Nord Ovest
Enrollment
62
Primary Endpoint
Brief Neuropshychological Examination

Overview

Brief Summary

The overall objective of the study is to compare upper limb cognitive and motor rehabilitation programs delivered via tele-rehabilitation and in-person, in order to evaluate their overall impact on the rehabilitation process of subjects with GCA outcomes at the end of the subacute phase.

Detailed Description

The study is a controlled clinical trial aimed at evaluating the efficacy and feasibility of cognitive and motor rehabilitation programs delivered in person or via tele-rehabilitation. Sixty-two subjects, aged 18 to 75, of both sexes, will be consecutively enrolled at the three participating centers. The sample size was calculated assuming a change of 15 points (standard deviation 20) on the Brief Neuropsychological Examination (BNE), with alpha = 0.05, beta = 0.2, and a power of 80%. A 10% margin was added to the resulting number (28 subjects per group) for potential dropouts. The ENB was chosen as the primary measure because, validated in the Italian population, it allows for a comprehensive, multidomain assessment that is sensitive to changes in the main cognitive domains (attention, memory, language, executive and praxic functions), also allowing for the evaluation of treatment efficacy over time, with short administration times and good tolerability in patients with GCA outcomes. Recent multicenter studies have confirmed its reliability and clinical relevance in this population. Subjects will be assigned to two treatment groups using block randomization, stratified by age, gender, and baseline functional level. This procedure was adopted to reduce potential bias and ensure greater comparability between groups. However, a geographical restriction will be maintained: patients unable to physically access the facility will be included in the tele-rehabilitation group (TG), but will follow the same stratification and randomization procedure, ensuring methodological consistency and allowing for dedicated sensitivity analyses.

The in-person treatment group (GP) will complete 50-minute sessions, three times a week for eight weeks, at the rehabilitation center. The tele-rehabilitation treatment group (TG) will complete a similar program at home, with the same frequency and duration, via dedicated platforms.

Sixty-two subjects (18-75 years old, both genders) will be consecutively enrolled at the three participating centers upon discharge from hospital rehabilitation. Patients will be assigned equally to the two groups (in-person treatment and tele-rehabilitation) using block randomization stratified by age, gender, and functional level.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Outcome of Severe Acquired Brain Injury (GAI) of various etiologies;
  • Age between 18 and 75 years
  • Level of Cognitive Functioning (LCF) at discharge from the hospital ward \>= 6;
  • One or more neuropsychological deficits in the areas of attention, memory, language, and executive functions;
  • Possible upper limb motor deficit;
  • Absence of general clinical complications that could interfere with rehabilitation treatment;
  • Cognitive and language functions sufficient to understand the instructions provided and give consent -

Exclusion Criteria

  • Level of Cognitive Functioning (LCF) at discharge from hospitalization ward \< 6;
  • Presence of previous deficits in neuropsychological and motor functions prior to the acute event;
  • Vulnerable subjects or those in emergency situations
  • Failure to provide informed consent.
  • Pregnant or intending to become pregnant during the enrollment period -

Arms & Interventions

Group Presence (GP)

Experimental

Patients in the in-person treatment group (GP) will undergo 50-minute sessions, three times a week, for a total of eight weeks using VRRS virtual reality systems (Khymeia, Padua, Italy), certified Class A medical devices.

Intervention: Group Presence (Device)

Group Tele-Rehabilitation

Active Comparator

The telerehabilitation treatment group (GT) will receive a similar motor and cognitive treatment program at home using the VRRS HomeKit device (Khymeia, Padua, Italy), another certified Class 1 medical device.

Intervention: Tele-rehabilitation (Device)

Outcomes

Primary Outcomes

Brief Neuropshychological Examination

Time Frame: Pre-intervetion and immediately after 8 weeks of intervention

Flug Meyer Upper Extremity Scale

Time Frame: Pre-intervetion and immediately after 8 weeks of intervention

Secondary Outcomes

  • System Usability Scale(Pre-intervetion and immediately after 8 weeks of intervention)
  • Client Satisfaction Questionnaire-8 Total scores range from 8 to 32, with the higher number indicating greater satisfaction(Pre-intervetion and immediately after 8 weeks of intervention)

Investigators

Sponsor
Azienda USL Toscana Nord Ovest
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Federico Posteraro

Head of rehabilitation department Versilia Hospital

Azienda USL Toscana Nord Ovest

Similar Trials